Latest period
$4.29M
YoY change
+37.0%
5Y CAGR
+18.9%
Peak year (2025)
$7.27M
Latest annual
$7.27M
Total Liabilities history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: $7.27M
Total Liabilities growth chart for Climb Bio (CLYM) from 2019 to 2025
Latest: +37.0%
Total Liabilities history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | $7.27M | +37.0% | +$1.96M | ||
| 2024 | $5.31M | +84.9% | +$2.44M | ||
| 2023 | $2.87M | -54.3% | −$3.41M | ||
| 2022 | $6.28M | +4.0% | +$239.00K | ||
| 2021 | $6.04M | +97.1% | +$2.98M | ||
| 2020 | $3.06M | +291.2% | +$2.28M | ||
| 2019 | $783.00K | — | — |
- 2025$7.27M+37.0%
- 2024$5.31M+84.9%
- 2023$2.87M-54.3%
- 2022$6.28M+4.0%
- 2021$6.04M+97.1%
- 2020$3.06M+291.2%
- 2019$783.00K—
Total Liabilities values are taken from Climb Bio's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's latest reported total liabilities is $4.29M. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Climb Bio (CLYM) reported total liabilities of $7.27M – surged 37.0% year-over-year.
Across 2020–2025 (5 years), Climb Bio total liabilities produced a CAGR of +18.9% – with mixed annual results across the window.
The highest annual total liabilities of $7.27M was reported in 2025. The lowest in the available history was $783.00K in 2019.
Climb Bio Total Liabilities by Year
Climb Bio Total Liabilities 2025: $7.27M
Climb Bio posted total liabilities of $7.27M in 2025, surged 37.0% from 2024. This figure represents the highest annual value in the available history.
Climb Bio Total Liabilities 2024: $5.31M
In 2024, Climb Bio reported total liabilities of $5.31M, surged 84.9% from 2023.
Climb Bio Total Liabilities 2023: $2.87M
Climb Bio total liabilities in 2023 was $2.87M, plunged 54.3% below 2022.
Climb Bio Total Liabilities 2022: $6.28M
2022's total liabilities for Climb Bio came in at $6.28M, edged up 4.0% from 2021.
Climb Bio Total Liabilities 2021: $6.04M
Climb Bio total liabilities in 2021 was $6.04M.
See more financial history for Climb Bio (CLYM).
Sector peers by Total Liabilities
Healthcare peers of Climb Bio (CLYM), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation